Goldman Sachs initiated coverage of ResMed (RMD) with a Buy rating and A$48.90 price target The firm says its Buy thesis is based on “robust” ...

The products can be used with BiPAP and CPAP machines from other manufacturers, and patients using those devices should ...

Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...

OSA impacts about 936 million people worldwide and occurs when the throat muscles relax and block the airway with a common ...

ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians: Our Bureau, Bengaluru Monday, January 6, 2025, 17:30 Hrs [IST] ResMed, the world’s leading he ...

ResMed Inc. (RMD), based in San Diego, California, is a leading provider of cloud-connected devices and digital health solutions, impacting millions of patients worldwide. With a market ...

ResMed is best known for creating medical devices for treating diseases such as sleep apnea and COPD. This includes making masks that are used with devices like CPAP machines, designed to be ...